Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 31, Number 9—September 2025

Dispatch

Imported Malaria and Congenital Acquisition in Infant, Portugal, 2024

Author affiliation: Global Health and Tropical Medicine, Associate Laboratory in Translation and Innovation Towards Global Health, Instituto de Higiene e Medicina Tropical, Universidade NOVA de Lisboa, Lisbon, Portugal (I. Lopes, E. Das Neves, A. Santos-Reis, L. Varandas, D. Lopes); Unidade Local de Saúde São José, Lisbon (J. Dias); Hospital of Vila Franca de Xira, Vila Franca de Xira, Portugal (M. Morais); Unidade Local de Saúde São José EPE Centro de Investigação, Lisbon (A.M. Garcia, L. Varandas)

Suggested citation for this article

Abstract

Plasmodium falciparum infection was diagnosed in a 3-month-old baby in Portugal by optical microscopy. The mother had had malaria in Angola 13 months earlier, before she emigrated to Portugal. She remained asymptomatic throughout and after pregnancy. We confirmed the diagnosis of an imported malaria case and congenital transmission using molecular techniques.

Imported malaria cases in Europe from sub-Saharan Africa countries can manifest with very low parasite densities and asymptomatic infections. Those infections can pose a public health threat, given the potential for onward transmission in areas with competent vectors and suitable conditions (13).

Congenital malaria in infants is rare because the placenta acts as an effective barrier preventing the transfer of malaria parasites from maternal to fetal circulatory system; transmission during labor is the most likely mechanism (4). Ultrasensitive molecular diagnostic tools detect infections in settings with low parasite density (5,6). Congenital malaria is not universally defined. Some authors define it as the presence of asexual forms of malaria parasites in an infant’s cord blood or peripheral blood during the first week of life, regardless of clinical symptoms (4,7). Others require the presence of parasites in the newborn’s peripheral blood on the first day of life for diagnosis (4,7). However, a timely diagnosis can be missed if a patient has no suggestive symptoms or clinical or travel history that prompt an early assessment. We report Plasmodium falciparum infection in a 3-month-old baby in Portugal.

The Study

A 3-month-old female infant was brought to a pediatric emergency department of Vila Franca de Xira Hospital (Vila Franca Xira, Portugal) with a 2-day history of fever and splenomegaly; maximum axillary temperature was 38.6°C. Initial laboratory tests revealed a hemoglobin level of 10.9 g/dL (reference threshold is 11.0 g/L for children 6–59 months of age), a leukocyte count of 10,500/mm3 (2,040/mm3 neutrophils and 5,970/mm3 lymphocytes) (reference ranges 7,300–16,600/mm3 for leukocytes, 1,500–6,900/mm3 for neutrophils, and 3,400–9,400/mm3 for lymphocytes), platelet count of 66,000/mm3 (reference range 180,000–440,000/mm3), and C-reactive protein level of 53.4 mg/L (reference range <10 mg/L). A peripheral blood smear revealed P. falciparum trophozoites; parasite count was estimated at 4.6%. Further investigation of family history revealed that the infant was born via cesarean delivery; infant and mother were discharged from hospital without any concerns. The infant had no history of traveling abroad, but her mother had moved to Portugal from Angola 13 months earlier. The mother had received artemether/lumefantrine treatment for P. falciparum infection in Angola 1 week before relocating to Portugal.

Because our findings were consistent with a suspected case of congenital malaria, we obtained samples from the mother and infant for molecular testing. We collected samples from the infant, with written consent from her mother, from the neonatal Guthrie card with blood collected via heel prick at the fourth day of life, during initial hospital admission, and at a follow-up appointment, at which we also took a sample from the mother. Maternal thick and thin blood smears did not reveal any malarial parasites; a rapid diagnostic test for malaria returned negative results.

Figure 1

Quantitative PCR amplification of samples from infant and mother in study of congenital malaria, Portugal. We obtained results from arithmetic average values of triplicate results. Additional curves represent standard results obtained by serial dilution to determine parasite quantification. Results were 0.07 parasites/µL from infant’s Guthrie card sample 4 days after birth; 1,178.13 parasites/µL from sample taken at hospital admission; 21.99 parasites/µL from sample taken at follow-up appointment; 0.03 parasites/µL from sample taken from the mother at follow-up appointment. RFU, relative fluorescence unit.

Figure 1. Quantitative PCR amplification of samples from infant and mother in study of congenital malaria, Portugal. We obtained results from arithmetic average values of triplicate results. Additional curves represent standard results...

Figure 2

Digital PCR results from samples from infant and mother in study of congenital malaria, Portugal. We obtained results from arithmetic average values (parasite/µL) of triplicate results. Results indicate the number of positive droplets in each sample: 1, taken from infant’s Guthrie card on day 4 after birth, 0.49 parasites/µL; 2, taken from infant at hospital admission, 30,000 parasites/µL; 3, taken from infant at follow-up appointment, 599.8 parasites/µL; and 4, taken from mother at follow-up, 0.5 parasites/µL. FAM, fluorescein amidite.

Figure 2. Digital PCR results from samples from infant and mother in study of congenital malaria, Portugal. We obtained results from arithmetic average values (parasite/µL) of triplicate results. Results indicate the number...

We performed total DNA extraction using a QIAamp DNA Mini Kit (QIAGEN, http://www.qiagen.com) on dried blood spots on Whatman filter paper. We tested samples by endpoint nested PCR, as described by Singh (8). We performed molecular assays (Table 1) to assess parasite density, using standard curves prepared with 10-fold dilutions of DNA obtained from the P. falciparum 3D7 clone; result range was 104 to 10−1 parasites/µL (Figure 1). We applied high-sensitivity quantitative PCR (qPCR) targeting the multicopy telomeric var genes to estimate the densities of the parasite. We performed digital PCR to confirm and compare results (Figure 2) (5).

Conclusions

This case highlights 2 key aspects for a better understanding of P. falciparum transmission: the role of imported, low-density asymptomatic cases as reservoirs and their potential contribution to congenital transmission. In Europe, ≈8,000 cases of imported malaria are reported annually (2); imported cases are mainly P. falciparum infections. Those populations can become a parasite reservoir that can pose significant risk to public health. Migrants may also display mild symptoms or be asymptomatic, often with submicroscopic parasitemia (2), which may be attributed to immunity acquired while residing in malaria-endemic regions (9). Such low levels of parasitemia can only be detected through sensitive molecular methods (10), such as qPCR-based techniques; we obtained the positive test result from this patient by nested PCR in the sample taken at hospital admission, when she was experiencing symptoms and parasitemia. In Portugal, there are potentially malaria-receptive areas and also a vector with some degree of competence (3). In non–malaria-endemic settings, availability of diagnostic tools varies by healthcare setting (Table 2). Nevertheless, clinicians should recognize the likelihood of congenital malaria and refer blood samples from suspected cases for testing.

var genes are known for their role in antigenic variation, enabling P. falciparum to evade the host immune response. The high copy number of var genes can enhance the sensitivity of detection methods. For instance, the use of multicopy subtelomeric targets has been shown to improve the detection of low-density infections that might otherwise be missed using standard assays such as 18ssRNA PCR (6). In our study, we established an accurate diagnosis for the mother through pfvarATS qPCR, which detected 0.03 parasites/µL, and digital PCR (dPCR), which detected 0.5 parasites/µL. Without the mother’s diagnosis, the child’s infection would have likely gone undetected and untreated. We have not established whether transmission to the infant was transplacental or from direct contact with maternal blood during labor. In most pregnancies resulting in congenital malaria, the mother’s infection tends to be symptomatic (11); malaria can also be diagnosed after uncomplicated asymptomatic pregnancies (11).

For our study, we defined congenital malaria as outlined in Oluput-Oluput (12) as the direct infection of an infant with malaria parasites from the mother before or during birth. Although all clinical indicators were consistent with congenital malaria, we pursued confirmation by detecting and quantifying parasite DNA in the Guthrie card sample taken on day 4 after birth. Both qPCR and dPCR confirmed the presence of P. falciparum parasites in the infant’s peripheral blood, with very low parasite densities (0.07 parasites/µL by qPCR and 0.49 parasites/µL by dPCR). Those findings align with the parasitemia levels observed in the mother, further supporting the likelihood of vertical transmission.

The delayed onset of symptoms in the infant can be attributed to several factors: the transfer of maternal antibodies through transplacental transfer and breastfeeding (13), low iron levels, and reduced erythropoiesis in newborns that do not favor Plasmodium spp. growth (14). Parasitemia might increase as maternal antibodies decline (15). In this case, the onset of symptoms occurred later than the previously reported median age, making the diagnosis more challenging (7). Furthermore, the nonspecific clinical signs of congenital malaria can be difficult to distinguish from other causes of sepsis (4). Our study highlights the importance of considering congenital malaria in the differential diagnosis of febrile infants born to mothers who have lived in malaria-endemic areas (7). We also emphasize the need for thorough analysis of blood smears in sepsis cases, particularly when thrombocytopenia is present (12).

In conclusion, this case underscores the utility of ultrasensitive detection targets and methods such as pfvartATS qPCR and dPCR for detecting submicroscopic malaria infections, particularly in asymptomatic migrant populations or populations at higher risk such as pregnant women and infants. Our findings emphasize the public health risk of overlooking hidden parasite reservoirs, which could hinder effective malaria control and prevention efforts in vulnerable groups.

Dr. Lopes is a senior technician at the Global Health and Tropical Medicine Research Centre, Instituto de Higiene e Medicina Tropical, NOVA University Lisbon. Her primary research and teaching interests are malaria and other neglected tropical diseases, focusing on development and capacity-building in tropical disease diagnostics and public health, mainly in Portuguese-speaking countries in Africa.

Top

Acknowledgments

We thank the patient’s mother for consenting to the publication of these results. We thank Rui Batista, Gonçalo Carvalho, and Sara Mateus for their invaluable technical support during the digital PCR experiments and analysis workflow.

Fundação para a Ciência e a Tecnologia supported this work (GHTM—UID/04413/2020 and LA-REAL–LA/P/0117/2020).

Top

References

  1. Corbacho-Loarte  MD, Crespillo-Andújar  C, Chamorro-Tojeiro  S, Norman  F, Pérez-Molina  JA, Martín  O, et al. Screening of imported malaria infection in asymptomatic migrants from Sub-Saharan Africa: A retrospective analysis of a 2010-2019 cohort. Travel Med Infect Dis. 2022;49:102411. DOIPubMedGoogle Scholar
  2. Pousibet-Puerto  J, Lozano-Serrano  AB, Soriano-Pérez  MJ, Vázquez-Villegas  J, Giménez-López  MJ, Cabeza-Barrera  MI, et al. Migration-associated malaria from Africa in southern Spain. Parasit Vectors. 2021;14:240. DOIPubMedGoogle Scholar
  3. Gomes  E, Capinha  C, Rocha  J, Sousa  C. Mapping risk of malaria transmission in mainland Portugal using a mathematical modelling approach. PLoS One. 2016;11:e0164788. DOIPubMedGoogle Scholar
  4. Bilal  JA, Malik  EE, Al-Nafeesah  A, Adam  I. Global prevalence of congenital malaria: A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2020;252:53442. DOIPubMedGoogle Scholar
  5. Dong  L, Li  W, Xu  Q, Gu  J, Kang  Z, Chen  J, et al. A rapid multiplex assay of human malaria parasites by digital PCR. Clin Chim Acta. 2023;539:708. DOIPubMedGoogle Scholar
  6. Hofmann  N, Mwingira  F, Shekalaghe  S, Robinson  LJ, Mueller  I, Felger  I. Ultra-sensitive detection of Plasmodium falciparum by amplification of multi-copy subtelomeric targets. PLoS Med. 2015;12:e1001788. DOIPubMedGoogle Scholar
  7. Prior  AR, Prata  F, Mouzinho  A, Marques  JG. Congenital malaria in a European country. BMJ Case Rep. 2012;2012:bcr2012007310. DOIGoogle Scholar
  8. Singh  B, Bobogare  A, Cox-Singh  J, Snounou  G, Abdullah  MS, Rahman  HA. A genus- and species-specific nested polymerase chain reaction malaria detection assay for epidemiologic studies. Am J Trop Med Hyg. 1999;60:68792. DOIPubMedGoogle Scholar
  9. Cirera  L, Sacoor  C, Meremikwu  M, Ranaivo  L, F Manun’Ebo  M, Arikpo  D, et al. The economic costs of malaria in pregnancy: evidence from four sub-Saharan countries. Gates Open Res. 2023;7:47. DOIPubMedGoogle Scholar
  10. Omer  S, Khalil  E, Ali  H, Sharief  A. Submicroscopic and multiple plasmodium falciparum infections in pregnant Sudanese women. N Am J Med Sci. 2011;3:13741. DOIPubMedGoogle Scholar
  11. Morven  S. Edwards. Fungal and protozoal infections. In: Fanaroff AA, Martin RJ, editors. Neonatal-perinatal medicine: diseases of the fetus and infant. 7th ed. St. Louis: Mosby; 2002. p. 751–752.
  12. Olupot-Olupot  P, Eregu  EIE, Naizuli  K, Ikiror  J, Acom  L, Burgoine  K. Neonatal and congenital malaria: a case series in malaria endemic eastern Uganda. Malar J. 2018;17:171. DOIPubMedGoogle Scholar
  13. Natama  HM, Moncunill  G, Vidal  M, Rouamba  T, Aguilar  R, Santano  R, et al. Associations between prenatal malaria exposure, maternal antibodies at birth, and malaria susceptibility during the first year of life in Burkina Faso. Infect Immun. 2023;91:e0026823. DOIPubMedGoogle Scholar
  14. Severe malaria. Trop Med Int Health. 2014;19(Suppl 1):7131. DOIPubMedGoogle Scholar
  15. Stassijns  J, van den Boogaard  W, Pannus  P, Nkunzimana  A, Rosanas-Urgell  A. Prevalence and diagnostics of congenital malaria in rural Burundi, a cross-sectional study. Malar J. 2016;15:4436. DOIPubMedGoogle Scholar

Top

Figures
Tables

Top

Suggested citation for this article: Lopes I, Dias J, Das Neves E, Morais M, Santos-Reis A, Garcia AM, et al. Imported malaria and congenital acquisition in infant, Portugal, 2024. Emerg Infect Dis. 2025 Sep [date cited]. https://doi.org/10.3201/eid3109.250536

DOI: 10.3201/eid3109.250536

Original Publication Date: August 20, 2025

1These authors contributed equally to this article.

Table of Contents – Volume 31, Number 9—September 2025

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.

Top

Comments

Please use the form below to submit correspondence to the authors or contact them at the following address:

Dinora Lopes, Universidade Nova de Lisboa, Instituto de Higiene e Medicina Tropical, UEI Tropical Clinic, Science and Community Support Service (SACC), Rua da Junqueira, 100 Lisbon, Lisbon 1349 008 Portugal

Send To

10000 character(s) remaining.

Top

Page created: August 01, 2025
Page updated: August 20, 2025
Page reviewed: August 20, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external